Risk-adapted individualized approaches including using PSA in conjunction with risk factors (e.g., genetics, race, family history), as well as incorporation of advanced magnetic resonance imaging (MRI) may improve the detection of significant prostate cancer and avoid the overdiagnosis of clinically insignificant disease [29]. Here, KLK3 is linked to Familial prostate cancer.